For example, RA patients who are under high dose of immunesuppressants at time of COVID-19 hospitalization would have a higher risk than benefit if administered IL-6, JAK or IL-1 inhibitor as this drugs will increase the possibility of serious hospital-acquired infections [91]. The gene discussed is IL6; the disease is rheumatoid arthritis.